幸运飞艇计划

• Lellahi SM, Azeem W, Hua Y, Gabriel B, Paulsen Rye K,聽Reikvam H, Kalland KH. GM-CSF, Flt3-L and IL-4 affect聽viability and function of conventional dendritic cell types 1听补苍诲 2. Front Immunol. 2023 Jan 12;13:1058963. doi: 10.3389/fimmu.2022.1058963. PMID: 36713392; PMCID: PMC9880532
• V枚lker T, Mazzonetto M, Slaattelid R, Strand R. Translating聽tools and indicators in territorial RRI. Front Res Metr Anal.听2023 Jan 9;7:1038970. doi: 10.3389/frma.2022.1038970. PMID:36700150; PMCID: PMC9868598.
• Farndale R, Sonnenberg A, DiPersio CM, Eble JA, Heino J,聽Gullberg D. What does it take to be a collagen receptor? Matrix聽Biol. 2023 Jan;115:128-132. doi: 10.1016/j.matbio.2022.12.004.听Epub 2022 Dec 24. PMID: 36574820.
• Fasmer KE, Gulati A, Dybvik JA, Wagner-Larsen KS, Lura N,聽Salvesen 脴, Forsse D, Trovik J, Pijnenborg JMA, Krakstad C,聽Haldorsen IS. Preoperative pelvic MRI and 2-[18F]FDG PET/CT for lymph node staging and prognostication in endometrial聽cancer-time to revisit current imaging guidelines? Eur Radiol.听2023 Jan;33(1):221-232. doi: 10.1007/s00330-022-08949-3. Epub聽2022 Jun 28. PMID: 35763096; PMCID: PMC9755079.
• Vrede SW, Kasius J, Bulten J, 鈥� and Pijnenborg JMA (incl.听Amant F). Relevance of Molecular Profiling in Patients with聽Low-Grade Endometrial Cancer. JAMA Netw Open. 2022 Dec聽1;5(12):e2247372. doi: 10.1001/jamanetworkopen.2022.47372.听PMID: 36525269.
• Sui L, Wang S, Ganguly D, El Rayes TP, Askeland C,聽B酶rretzen A, Sim D, Halvorsen OJ, Knutsvik G, Arnes J,聽Aziz S, Haukaas S, Foulkes WD, Bielenberg DR, Ziemys聽A, Mittal V, Brekken RA, Akslen LA, Watnick RS. PRSS2聽remodels the tumor microenvironment via repression of Tsp1聽to stimulate tumor growth and progression. Nat Commun. 2022聽Dec 27;13(1):7959. doi: 10.1038/s41467-022-35649-9. PMID:36575174; PMCID: PMC9794699.
• Rahman MA, Engelsen AST, Sarowar S, Bindesb酶ll聽C, Birkeland E, Goplen D, Lotsberg ML, Knappskog聽S, Simonsen A, Chekenya M. Bortezomib abrogates聽temozolomide-induced autophagic flux through an ATG5聽dependent pathway. Front Cell Dev Biol. 2022 Dec 22;10:1022191.听doi: 10.3389/fcell.2022.1022191. PMID: 36619857; PMCID:聽PMC9814514.
• Barrett JE, Jones A, Evans I, 鈥� and Widschwendter M聽(incl. Bj酶rge L). The WID-EC test for the detection and risk聽prediction of endometrial cancer. Int J Cancer. 2022 Dec 19.听doi: 10.1002/ijc.34406. Epub ahead of print. PMID: 36533702
• Othman J, Meggendorfer M, Tiacci E, 鈥� and Falini B (incl.听Andresen V, Gjertsen BT). Overlapping features of therapyrelated and de novoNPM1-mutated AML. Blood. 2022 Dec聽12:blood.2022018108. doi: 10.1182/blood.2022018108. Epub聽ahead of print. PMID: 36508705.
• Berg HF, Engerud H, Myrvold M, Lien HE, Hjelmeland ME,聽Halle MK, Woie K, Hoivik EA, Haldorsen IS, Vintermyr聽O, Trovik J, Krakstad C. Mismatch repair markers in聽preoperative and operative endometrial cancer samples;聽expression concordance and prognostic value. Br J Cancer.听2022 Dec 8. doi: 10.1038/s41416-022-02063-3. Epub ahead of聽print. PMID: 36482191.
• Kang J, Cairns J. Exploring uncertainty and use of real-world聽data in the National Institute for Health and Care Excellence聽single technology appraisals of targeted cancer therapy. BMC聽Cancer. 2022 Dec 5;22(1):1268. doi: 10.1186/s12885-022-10350-8.听PMID: 36471259; PMCID: PMC9724266.
• Thurfjell V, Micke P, Yu H, Krupar R, Svensson MA,聽Brunnstr枚m H, Lamberg K, Moens LNJ, Strell C, Gulyas聽M, Helenius G, Yoshida A, Goldmann T, Mattsson JSM.听Comparison of ROS1-rearrangement detection methods in a聽cohort of surgically resected non-small cell lung carcinomas.听Transl Lung Cancer Res. 2022 Dec;11(12):2477-2494. doi:10.21037/tlcr-22-504. PMID: 36636421; PMCID: PMC9830269.
• Gaafar NM, Osman TA, Elsheikh M, Ahmed IA, Dongre H,聽Fromreide S, Suleiman AM, Johannessen AC, Nginamau ES,聽Costea DE. Epithelial PD-L1 expression at tumor front predicts聽overall survival in a cohort of oral squamous cell carcinomas聽from Sudan. Clin Exp Dent Res. 2022 Dec;8(6):1467-1477. doi:10.1002/cre2.666. Epub 2022 Sep 30. PMID: 36177667; PMCID:聽PMC9760153.
• Zeltz C, Navab R, Heljasvaara R, Kusche-Gullberg M, Lu N,聽Tsao MS, Gullberg D. Integrin 伪11尾1 in tumor fibrosis: more聽than just another cancer-associated fibroblast biomarker? J Cell聽Commun Signal. 2022 Dec;16(4):649-660. doi: 10.1007/s12079-022-00673-3. Epub 2022 Apr 4. PMID: 35378690; PMCID:聽PMC8978763.
• Herzog C, Mar铆n F, Jones A, 鈥� and Widschwendter M聽(incl. Bj酶rge L). A Simple Cervicovaginal Epigenetic Test聽for Screening and Rapid Triage of Women with Suspected聽Endometrial Cancer: Validation in Several Cohort and Case/Control Sets. J Clin Oncol. 2022 Nov 20;40(33):3828-3838. doi:10.1200/JCO.22.00266. Epub 2022 Aug 24. PMID: 36001862;聽PMCID: PMC9671754.
• Sofiyeva N, Krakstad C, Halle MK, O鈥橫ara TA, Romundstad聽P, Hveem K, Vatten L, L酶nning PE, Gansmo LB, Knappskog聽S. APOBEC3A/B deletion polymorphism and endometrial聽cancer risk. Cancer Med. 2022 Nov 16. doi: 10.1002/cam4.5448.听Epub ahead of print. PMID: 36394079.听
• Lee SY, Robertson C, Diot A, Meuray V, Bourdon JC, Bissell聽MJ. 螖133p53 coordinates ECM-driven morphogenesis and聽gene expression in three-dimensional mammary epithelial聽acini. J Cell Sci. 2022 Nov 1;135(21):jcs259673. doi: 10.1242/jcs.259673. Epub 2022 Nov 4. PMID: 36239052; PMCID:聽PMC9687550.
• Lomakin A, Svedlund J, Strell C, 鈥� and Yates LR. Spatial聽genomics maps the structure, nature and evolution of cancer聽clones. Nature. 2022 Nov;611(7936):594-602. doi: 10.1038/s41586-022-05425-2. Epub 2022 Nov 9. PMID: 36352222;聽PMCID: PMC9668746.
• Ingebriktsen LM, Finne K, Akslen LA, Wik E. A novel agerelated gene expression signature associates with proliferation听补苍诲 disease progression in breast cancer. Br J Cancer. 2022聽Nov;127(10):1865-1875. doi: 10.1038/s41416-022-01953-w.听Epub 2022 Aug 23. PMID: 35995935; PMCID: PMC9643541.听
• Tettero JM, Al-Badri WKW, Ngai LL, 鈥� and Cloos J (incl.听Gjertsen BT). Concordance in measurable residual disease聽result after first and second induction cycle in acute myeloid聽leukemia: An outcome- and cost-analysis. Front Oncol. 2022 Oct聽10;12:999822. doi: 10.3389/fonc.2022.999822. PMID: 36300090;聽PMCID: PMC9589259.听
• Guldvik IJ, Braadland PR, Sivanesan S, Ramberg H,聽Kristensen G, Tennstedt P, Roder A, Schlomm T, Berge V,聽Eri LM, Lilleby W, Mills IG, Tasken KA. Low Blood Levels聽of LRG1 Before Radical Prostatectomy Identify Patients with聽High Risk of Progression to Castration-resistant Prostate聽Cancer. Eur Urol Open Sci. 2022 Oct 4;45:68-75. doi: 10.1016/j.听euros.2022.09.002. eCollection 2022 Nov. PMID: 36353660.听
• Chakravarthy A, Reddin I, Henderson S, 鈥� and Fenton聽TR (incl. Halle MK, Krakstad C, Salvesen H). Integrated聽analysis of cervical squamous cell carcinoma cohorts from聽three continents reveals conserved subtypes of prognostic聽significance. Nat Commun. 2022 Oct 7;13(1):5818. doi: 10.1038/s41467-022-33544-x. PMID: 36207323; PMCID: PMC9547055.
• Steffens Reinhardt L, Zhang X, Groen K, Morten BC, De聽Iuliis GN, Braithwaite AW, Bourdon JC, Avery-Kiejda KA.听Alterations in the p53 isoform ratio govern breast cancer聽cell fate in response to DNA damage. Cell Death Dis. 2022聽Oct 28;13(10):907. doi: 10.1038/s41419-022-05349-9. PMID:聽36307393; PMCID: PMC9616954.
• Aamdal E, Skovlund E, Jacobsen KD, Straume O, Kersten C,聽Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug聽A, Nyakas M, Hagene KT, Holmsen K, Aamdal S, Kaasa S,聽Guren TK, Kyte JA. Health-related quality of life in patients聽with advanced melanoma treated with ipilimumab: prognostic聽implications and changes during treatment. ESMO Open. 2022聽Oct;7(5):100588. doi: 10.1016/j.esmoop.2022.100588. Epub 2022聽Sep 16. PMID: 36116420; PMCID: PMC9588897.听
• Sommerfelt H, Sandvik LF, Bachmann IM, Brekke RL,聽Svendsen HL, Guttormsen AB, Aziz S, Dillek氓s H, Straume聽O. Toxic epidermal necrolysis after immune checkpoint聽inhibition, case report, and review of the literature. Acta Oncol.
  2022 Oct;61(10):1295-1299. doi: 10.1080/0284186X.2022.2119099.听Epub 2022 Sep 8. PMID: 36073292.听
• Kang J, Cairns J. 鈥淒on鈥檛 Think Twice, It鈥檚 All Right鈥�: Using聽Additional Data to Reduce Uncertainty Regarding Oncologic聽Drugs Provided Through Managed Access Agreements in聽England. Pharmacoecon Open. 2022 Sep 20. doi: 10.1007/s41669-022-00369-9. Epub ahead of print. PMID: 36123583.
• Huuhtanen J, Ilander M, Yadav B, 鈥� and Mustjoki S (incl.听Gjertsen BT). IFN-伪 with dasatinib broadens the immune聽repertoire in patients with chronic-phase chronic myeloid聽leukemia. J Clin Invest. 2022 Sep 1;132(17):e152585. doi:10.1172/JCI152585. PMID: 36047494; PMCID: PMC9433106.听
• Rodriguez-Tirado C, Entenberg D, Li J, Qian B-Z, Condeelis聽JS, Pollard JW. Interleukin 4 Controls the Pro-Tumoral Role聽of Macrophages in Mammary Cancer Pulmonary Metastasis聽in Mice. Cancers (Basel). 2022 Sep 5;14(17):4336. doi: 10.3390/
  cancers14174336. PMID: 36077870.
• Che H, Jatsenko T, Lenaerts L, 鈥� and Vermeesch JR (incl. Amant F). Pan-Cancer Detection and Typing by Mining聽Patterns in Large Genome-Wide Cell-Free DNA Sequencing聽Datasets. Clin Chem. 2022 Sep 1;68(9):1164-1176. doi: 10.1093/clinchem/hvac095. PMID: 35769009.
• Wagner-Larsen KS, Lura N, Salvesen 脴, Halle MK, Forsse聽D, Trovik J, Smit N, Krakstad C, Haldorsen IS. Interobserver聽agreement and prognostic impact for MRI-based 2018 FIGO聽staging parameters in uterine cervical cancer. Eur Radiol. 2022聽Sep;32(9):6444-6455. doi: 10.1007/s00330-022-08666-x. Epub聽2022 Mar 24. PMID: 35332408; PMCID: PMC9381622.
• Mart铆nez-Nieto GA, Teppo HR, Petrelius N, Izzi V,聽Devarajan R, Pet盲ist枚 T, Liu H, Kim KS, Karppinen聽SM, Ruotsalainen H, Koivunen J, M盲ki JM, Walker GC,聽Pihlajaniemi T, Gullberg D, Heljasvaara R. Upregulated聽integrin 伪11 in the stroma of cutaneous squamous cell聽carcinoma promotes skin carcinogenesis. Front Oncol. 2022聽Aug 8;12:981009. doi: 10.3389/fonc.2022.981009. PMID:36003785; PMCID: PMC9393502.
• Erickson A, He M, Berglund E, 鈥� and Lundeberg J (incl.听Mills IG). Spatially resolved clonal copy number alterations in聽benign and malignant tissue. Nature. 2022 Aug;608(7922):360-367. doi: 10.1038/s41586-022-05023-2. Epub 2022 Aug 10.听PMID: 35948708.
• Van Nyen T, Planque M, van Wagensveld L, 鈥� and Amant聽F. Serine metabolism remodeling after platinum-based聽chemotherapy identifies vulnerabilities in a subgroup of聽resistant ovarian cancers. Nat Commun. 2022 Aug 5;13(1):4578.听doi: 10.1038/s41467-022-32272-6. PMID: 35931688.听
• Krebs N, Klein L, Wegwitz F, Espinet E, Maurer HC, Tu聽M, Penz F, K眉ffer S, Xu X, Bohnenberger H, Cameron S,聽Brunner M, Neesse A, Kishore U, Hessmann E, Trumpp聽A, Str枚bel P, Brekken RA, Ellenrieder V, Singh SK. Axon聽guidance receptor ROBO3 modulates subtype identity and聽prognosis via AXL-associated inflammatory network in聽pancreatic cancer. JCI Insight. 2022 Aug 22;7(16):e154475. doi:10.1172/jci.insight.154475.PMID: 35993361.听
• Larrieu CM, Storevik S, Guyon J, Pagano Zottola AC,聽Bouchez CL, Derieppe MA, Tan TZ, Miletic H, Lorens聽J, Tronstad KJ, Daubon T, R酶sland GV. Refining the聽Role of Pyruvate Dehydrogenase Kinases in Glioblastoma聽Development. Cancers (Basel). 2022 Aug 2;14(15):3769.听doi: 10.3390/cancers14153769. PMID: 35954433; PMCID:聽PMC9367285.听
• Fosse V, Oldoni E, Gerardi C, Banzi R, Fratelli M, Bietrix聽F, Ussi A, Andreu AL, McCormack E, The Permit Group.听Evaluating Translational Methods for Personalized Medicine-A聽Scoping Review. J Pers Med. 2022 Jul 19;12(7):1177. doi:10.3390/jpm12071177. PMID: 35887673; PMCID: PMC9324577.
• Poulose N, Forsythe N, Polonski A, Gregg G, Maguire S,聽Fuchs M, Minner S, Sauter G, McDade SS, Mills IG. VPRBP聽Functions Downstream of the Androgen Receptor and OGT聽to Restrict p53 Activation in Prostate Cancer. Mol Cancer Res.
  2022 Jul 6;20(7):1047-1060. doi: 10.1158/1541-7786.MCR-21-0477. PMID: 35348747.
• Helland 脜, Russnes HG, Fagereng GL, 鈥� and Smeland S聽(incl. Bj酶rge L, Gjertsen BT). Correction to: Improving public聽cancer care by implementing precision medicine in Norway:聽IMPRESS-Norway. J Transl Med. 2022 Jul 15;20(1):317. doi:
  10.1186/s12967-022-03518-0. Erratum for: J Transl Med. 2022聽May 14;20(1):225. PMID: 35841045; PMCID: PMC9284821.听
• Clarsen B, Nylenna M, Klitkou ST, 鈥� and Knudsen AKS聽(incl. Norheim OF). Changes in life expectancy and disease聽burden in Norway, 1990-2019: an analysis of the Global聽Burden of Disease Study 2019. Lancet Public Health. 2022聽Jul;7(7):e593-e605. doi: 10.1016/S2468-2667(22)00092-5. PMID:聽35779543; PMCID: PMC9253891.听
• Pianigiani G, Rocchio F, Peruzzi S, Andresen V, Bigerna聽B, Sorcini D, Capurro M, Gjertsen BT, Sportoletti P, Di聽Ianni M, Martelli MP, Brunetti L, Falini B. The absent/low聽expression of CD34 in NPM1-mutated AML is not related to聽cytoplasmic dislocation of NPM1 mutant protein. Leukemia.听2022 Jul;36(7):1931-1934. doi: 10.1038/s41375-022-01593-2.听Epub 2022 May 14. PMID: 35568767; PMCID: PMC9252915.
• Shalabi S and LaBarge MA. Cellular and molecular聽mechanisms of breast cancer susceptibility. Clinical Sciences聽(London) 2022 Jul 15;136(13):1025-1043. doi: 10.1042/CS20211158. PMID: 35786748.听
• Barrett JJE, Herzog C, Kim YN, Bartlett TE, Jones A, Evans I,聽Cibula D, Zikan M, Bj酶rge L, Harbeck N, Colombo N, Howell聽SJ, R氓destad AF, Gemzell-Danielsson K, Widschwendter聽M. Author Correction: Susceptibility to hormone-mediated聽cancer is reflected by different tick rates of the epithelial and聽general epigenetic clock. Genome Biol. 2022 Jun 29;23(1):142.听doi: 10.1186/s13059-022-02704-z. Erratum for: Genome Biol.听2022 Feb 22;23(1):52. PMID: 35768851; PMCID: PMC9241178.听
• Kleinmanns K, Gullaksen SE, Bredholt G, Davidson B,聽Torkildsen CF, Grindheim S, Bj酶rge L, McCormack E.听Humanized Ovarian Cancer Patient-Derived Xenografts for聽Improved Preclinical Evaluation of Immunotherapies. Cancers聽(Basel). 2022 Jun 23;14(13):3092. doi: 10.3390/cancers14133092.听PMID: 35804867; PMCID: PMC9265069.听
• Karunamuni RA, Huynh-Le MP, Fan CC, 鈥� and Seibert聽TM (incl. Mills IG). Performance of African-ancestry-specific聽polygenic hazard score varies according to local ancestry in聽8q24. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):229-237.听doi: 10.1038/s41391-021-00403-7. Epub 2021 Jun 14. PMID:聽34127801.听
• Lura N, Wagner-Larsen KS, Forsse D, Trovik J, Halle MK,聽Bertelsen BI, Salvesen 脴, Woie K, Krakstad C, Haldorsen聽IS. What MRI-based tumor size measurement is best for聽predicting long-term survival in uterine cervical cancer?聽Insights Imaging. 2022 Jun 17;13(1):105. doi: 10.1186/s13244-022-01239-y. PMID: 35715582; PMCID: PMC9206052.听
• Madland K, Bjorge L, Sm氓stuen MC, D酶rum A, Vistad I.听Symptomatic or asymptomatic recurrence of ovarian cancer:聽does it influence survival? Int J Gynecol Cancer. 2022 Jun 9:ijgc2022-003361. doi: 10.1136/ijgc-2022-003361. Epub ahead of
  print. PMID: 35680138.听
• Steffens Reinhardt L, Groen K, Morten BC, Bourdon JC,聽Avery-Kiejda KA. Cytoplasmic p53尾 Isoforms Are Associated聽with Worse Disease-Free Survival in Breast Cancer. Int J Mol聽Sci. 2022 Jun 15;23(12):6670. doi: 10.3390/ijms23126670. PMID:
  35743117; PMCID: PMC9223648.听
• Bergholtz H, Lien T, Lingaas F, S酶rlie T. Comparative analysis聽of the molecular subtype landscape in canine and human聽mammary gland tumors. J Mammary Gland Biol Neoplasia. 2022聽Jun;27(2):171-183. doi: 10.1007/s10911-022-09523-9. Epub 2022
  Aug 6. PMID: 35932380; PMCID: PMC9433360.
• Tranv氓g EJ, Haaland 脴A, Robberstad B, Norheim OF.听Appraising Drugs Based on Cost-effectiveness and Severity聽of Disease in Norwegian Drug Coverage Decisions.听JAMA Netw Open. 2022 Jun 1;5(6):e2219503. doi: 10.1001/jamanetworkopen.2022.19503. PMID: 35767256; PMCID:聽PMC9244608.
• Romaine A, Melleby AO, Alam J, Lobert VH, Lu N,聽Lockwood FE, Hasic A, Lunde IG, Sjaastad I, Stenmark聽H, Herum KM, Gullberg D, Christensen G. Integrin 伪11尾1听补苍诲 syndecan-4 dual receptor ablation attenuate cardiac聽hypertrophy in the pressure overloaded heart. Am J Physiol聽Heart Circ Physiol. 2022 Jun 1;322(6):H1057-H1071. doi: 10.1152/ajpheart.00635.2021. Epub 2022 May 6. PMID: 35522553.听
• Das R, Virlan MJR, Xenaki V, Kulasekara KK, Lukandu O,聽Neppelberg E, Vintermyr OK, Johannessen AC, Calenic聽B, Costea DE. Granulocyte macrophage-colony stimulating聽factor and keratinocyte growth factor control of early stages聽of differentiation of oral epithelium. Eur J Oral Sci. 2022聽Jun;130(3):e12867. doi: 10.1111/eos.12867. Epub 2022 Apr聽22. PMID: 35452148; PMCID: PMC9322408.
• Schiza A, Thurfjell V, Stenmark Tullberg A, Olofsson H,聽Lindberg A, Holmberg E, Bremer T, Micke P, Karlsson聽P, W盲rnberg F, Strell C. Tumour-infiltrating lymphocytes聽add prognostic information for patients with low-risk DCIS:聽findings from the SweDCIS randomised radiotherapy trial. Eur聽J Cancer. 2022 Jun;168:128-137. doi: 10.1016/j.ejca.2022.01.016.听Epub 2022 Feb 27. PMID: 35236568.听
• Vanbraband J, Van Damme N, Bouche G, Silversmit聽G, De Geyndt A, de Jonge E, Jacomen G, Goffin F,聽Denys H, Amant F. Completeness and selection bias of a聽Belgian multidisciplinary, registration-based study on the聽EFFectiveness and quality of Endometrial Cancer Treatment聽(EFFECT). BMC Cancer. 2022 Jun 1;22(1):600. doi: 10.1186/s12885-022-09671-5.PMID: 35650593.听
• Hua Y, Yuan X, Shen YH, Wang J, Azeem W, Yang S, Gade聽A, Lellahi SM, 脴yan AM, Ke X, Zhang WD, Kalland KH.听Novel STAT3 Inhibitors Targeting STAT3 Dimerization by聽Binding to the STAT3 SH2 Domain. Front Pharmacol. 2022 May聽27;13:836724. doi: 10.3389/fphar.2022.836724. PMID: 35712699;聽PMCID: PMC9196127.
• Perrone MG, Vitale P, Miciaccia M, Ferorelli S, Centonze聽A, Solidoro R, Munzone C, Bonaccorso C, Fortuna CG,聽Kleinmanns K, Bj酶rge L, Scilimati A. Fluorochrome聽Selection for Imaging Intraoperative Ovarian Cancer Probes.听Pharmaceuticals (Basel). 2022 May 26;15(6):668. doi: 10.3390/ph15060668. PMID: 35745587; PMCID: PMC9230671.
• Helland 脜, Russnes HG, Fagereng GL, 鈥� and Smeland S.听(incl. Bj酶rge L, Gjertsen BT). Improving public cancer care聽by implementing precision medicine in Norway: IMPRESSNorway. J Transl Med. 2022 May 14;20(1):225. doi: 10.1186/s12967-022-03432-5. Erratum in: J Transl Med. 2022 Jul聽15;20(1):317. PMID: 35568909; PMCID: PMC9107632.
• Hodneland E, Kaliyugarasan S, Wagner-Larsen KS, Lura聽N, Andersen E, Bartsch H, Smit N, Halle MK, Krakstad聽C, Lundervold AS, Haldorsen IS. Fully Automatic WholeVolume Tumor Segmentation in Cervical Cancer. Cancers聽(Basel). 2022 May 11;14(10):2372. doi: 10.3390/cancers14102372.听PMID: 35625977; PMCID: PMC9139985.听
• Task茅n K, Russnes HEG, Aas E, 鈥� and Helland 脜 (incl.听Bj酶rge L, Gjertsen BT, Hovland R). A national precision聽cancer medicine implementation initiative for Norway. Nat聽Med. 2022 May;28(5):885-887. doi: 10.1038/s41591-022-01777-4.听PMID: 35513529.
• Dareng EO, Tyrer JP, Barnes DR, 鈥� and Pharoah PDP (incl.听Bjorge L). Correction: Polygenic risk modeling for prediction聽of epithelial ovarian cancer risk. Eur J Hum Genet. 2022聽May;30(5):630-631. doi: 10.1038/s41431-022-01085-y. Erratum聽for: Eur J Hum Genet. 2022 Mar;30(3):349-362. PMID: 35314806;聽PMCID: PMC9090804.
• Engelsen AST, Lotsberg ML, Abou Khouzam R, Thiery JP,聽Lorens JB, Chouaib S, Terry S. Dissecting the Role of AXL in聽Cancer Immune Escape and Resistance to Immune Checkpoint聽Inhibition. Front Immunol. 2022 Apr 27;13:869676. doi: 10.3389/fimmu.2022.869676. PMID: 35572601; PMCID: PMC9092944
• Lotsberg ML, R酶sland GV, Rayford AJ, Dyrstad SE, Ekanger聽CT, Lu N, Frantz K, Stuhr LEB, Ditzel HJ, Thiery JP, Akslen聽LA, Lorens JB, Engelsen AST. Intrinsic Differences in聽Spatiotemporal Organization and Stromal Cell Interactions聽Between Isogenic Lung Cancer Cells of Epithelial and聽Mesenchymal Phenotypes Revealed by High-Dimensional聽Single-Cell Analysis of Heterotypic 3D Spheroid Models. Front聽Oncol. 2022 Apr 22;12:818437. doi: 10.3389/fonc.2022.818437.听PMID: 35530312; PMCID: PMC9076321.
• Huynh-Le MP, Karunamuni R, Fan CC, 鈥� and Seibert聽TM (incl. Mills IG). Prostate cancer risk stratification聽improvement across multiple ancestries with new polygenic聽hazard score. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):755-761. doi:10.1038/s41391-022-00497-7. Epub 2022 Feb 12. PMID:聽35152271.
• Wohlmuth C, Djedovic V, Kjaer SK, 鈥� and May T (incl.听Thomsen LCV, Bjorge L). CA-125 Levels Are Predictive of聽Survival in Low-Grade Serous Ovarian Cancer-A Multicenter聽Analysis. Cancers (Basel). 2022 Apr 13;14(8):1954. doi: 10.3390/cancers14081954. PMID: 35454861; PMCID: PMC9024456.
• Moshina N, Falk RS, Botteri E, Larsen M, Akslen LA,聽Cairns JA, Hofvind S. Quality of life among women with聽symptomatic, screen-detected, and interval breast cancer,听补苍诲 for women without breast cancer: a retrospective聽cross-sectional study from Norway. Qual Life Res. 2022聽Apr;31(4):1057-1068. doi: 10.1007/s11136-021-03017-7. Epub聽2021 Oct 26. PMID: 34698976; PMCID: PMC8547129.听
• Graham N, Pollard JW. An acid trip activates protumoral聽macrophages to promote hepatocellular carcinoma聽malignancy. J Clin Invest. 2022 Apr 1;132(7):e158562. doi:10.1172/JCI158562. PMID: 35362482.听
• Thy JE, Bhargava S, Larsen M, Akslen LA, Hofvind S.听Early screening outcomes among non-immigrants and聽immigrants targeted by BreastScreen Norway, 2010-2019.听Scand J Public Health. 2022 Mar 31:14034948221078701. doi:10.1177/14034948221078701. Epub ahead of print. PMID:聽35361004.
• Rajthala S, Parajuli H, Dongre HN, Lj酶kjel B, Hoven KM,聽Kvalheim A, Lybak S, Neppelberg E, Sapkota D, Johannessen聽AC, Costea DE. MicroRNA-138 Abates Fibroblast Motility聽with Effect on Invasion of Adjacent Cancer Cells. Front Oncol.听2022 Mar 17;12:833582. doi: 10.3389/fonc.2022.833582. PMID:聽35371970; PMCID: PMC8968121.听
• Li H, Liu Z, Liu L, 鈥� and Brennen RA (incl. Rayford A,聽Gabra H, Lorens JB). AXL targeting restores PD-1 blockade聽sensitivity of STK11/LKB1 mutant NSCLC through expansion聽of TCF1+ CD8 T cells. Cell Rep Med. 2022 Mar 15;3(3):100554.
  doi: 10.1016/j.xcrm.2022.100554. PMID: 35492873; PMCID:PMC9040166.
• Rana N, Suliman S, Mohamed-Ahmed S, Gavasso S, Gjertsen聽BT, Mustafa K. Systemic and local innate immune responses聽to surgical co-transplantation of mesenchymal stromal cells听补苍诲 biphasic calcium phosphate for bone regeneration.
  Acta Biomater. 2022 Mar 15;141:440-453. doi: 10.1016/j.听actbio.2021.12.027. Epub 2021 Dec 28. PMID: 34968726.听
• Ekanger CT, Zhou F, Bohan D, and Engelsen AST 鈥β�(incl. Lotsberg ML, Ramnefjell M, R酶sland GV, Lu N,聽Halvorsen T, Akslen LA, Lorens JB). Human Organotypic聽Airway and Lung Organoid Cells of Bronchiolar and Alveolar聽Differentiation Are Permissive to Infection by Influenza and聽SARS-CoV-2 Respiratory Virus. Front Cell Infect Microbiol. 2022聽Mar 14;12:841447. doi: 10.3389/fcimb.2022.841447. PMID:聽35360113; PMCID: PMC8964279.听
• Dareng EO, Tyrer JP, Barnes DR, 鈥� and Pharoah PDP聽(incl. Bjorge L, Thomsen LCV). Polygenic risk modeling for聽prediction of epithelial ovarian cancer risk. Eur J Hum Genet.听2022 Mar;30(3):349-362. doi: 10.1038/s41431-021-00987-7. Epub
  2022 Jan 14. Erratum in: Eur J Hum Genet. 2022 Mar 22; PMID:聽35027648; PMCID: PMC8904525.
• Fletcher CE, Deng L, Orafidiya F, 鈥� and Bevan CL (incl.听Mills IG). A non-coding RNA balancing act: miR-346-induced聽DNA damage is limited by the long non-coding RNA NORAD聽in prostate cancer. Mol Cancer. 2022 Mar 22;21(1):82. doi:10.1186/s12943-022-01540-w. PMID: 35317841.
• Hofvind S, Knutsvik G, Holen 脜S, Tsuruda KM,聽Akslen LA. Detection and significance of small and low聽proliferation breast cancer. J Med Screen. 2022 Mar;29(1):32-37. doi: 10.1177/09691413211023970. Epub 2021 Jun 22. PMID:聽34157879.
• Corti, L., Di Stefano, N., Bertolaso, M. (2022, June), Artificial聽Emotions: Toward a Human-Centric Ethics, International聽Journal of Social Robotics
• Barrett JE, Herzog C, Kim YN, Bartlett TE, Jones A, Evans I,聽Cibula D, Zikan M, Bj酶rge L, Harbeck N, Colombo N, Howell聽SJ, R氓destad AF, Gemzell-Danielsson K, Widschwendter聽M. Susceptibility to hormone-mediated cancer is reflected聽by different tick rates of the epithelial and general epigenetic聽clock. Genome Biol. 2022 Feb 22;23(1):52. doi: 10.1186/s13059-022-02603-3. Erratum in: Genome Biol. 2022 Jun 29;23(1):142. PMID: 35189945; PMCID: PMC8862470.听
• Azeem W, Olsen JR, Hellem MR, Hua Y, Marvyin K, Ke X,聽脴yan AM, Kalland KH. Proteasome-Mediated Regulation聽of GATA2 Expression and Androgen Receptor Transcription聽in Benign Prostate Epithelial Cells. Biomedicines. 2022 Feb聽17;10(2):473. doi: 10.3390/biomedicines10020473. PMID:聽35203681; PMCID: PMC8962351.听
• Barrett JE, Jones A, Evans I, Reisel D, Herzog C, Chindera聽K, Kristiansen M, Leavy OC, Manchanda R, Bj酶rge L, Zikan聽M, Cibula D, Widschwendter M. The DNA methylome of聽cervical cells can predict the presence of ovarian cancer.听Nat Commun. 2022 Feb 1;13(1):448. doi: 10.1038/s41467-021-26615-y. PMID: 35105887; PMCID: PMC8807742.听
• Barrett JE, Herzog C, Jones A 鈥� and Widschwendter M (incl.听Bj酶rge L). The WID-BC-index identifies women with primary聽poor prognostic breast cancer based on DNA methylation聽in cervical samples. Nat Commun. 2022 Feb 1;13(1):449. doi:
  10.1038/s41467-021-27918-w. PMID: 35105882; PMCID:聽PMC8807602.
• Robinson, A, Burgess, M, Webb, S, Louwe, PA, Ouyang,聽Z, Skola, D, Han, C,Z, Batada, N.N, Gonz谩lez-Huici, V.,聽Cassetta, L., Glass, C.K., Jenkins, S.J., Pollard, J.W. Systemic聽influences of mammary cancers on monocytes in mice. Cancers聽(Basel). 2022 Feb 7;14(3):833. doi: 10.3390/cancers14030833.听PMID: 35159100.听
• Bakunina K, Putter H, Versluis J, Koster EAS, van der聽Holt B, Manz MG, Breems DA, Gjertsen BT, Cloos J, Valk聽PJM, Passweg J, Pabst T, Ossenkoppele GJ, L枚wenberg B,聽Cornelissen JJ, de Wreede LC. The added value of multistate modelling in a randomized controlled trial: The HOVON聽102 study re-analyzed. Cancer Med. 2022 Feb;11(3):630-640.听doi: 10.1002/cam4.4392. Epub 2021 Dec 24. PMID: 34953042;聽PMCID: PMC8817075.
• Malani D, Kumar A, Br眉ck O, 鈥� and Porkka K (incl.听Helles酶y M, Gjertsen BT). Implementing a Functional聽Precision Medicine Tumor Board for Acute Myeloid Leukemia.听Cancer Discov. 2022 Feb;12(2):388-401. doi: 10.1158/2159-8290.听CD-21-0410. Epub 2021 Nov 17. PMID: 34789538; PMCID:聽PMC9762335.
• Samson S, Northey JJ, Goga A, Flink CL, Weaver VM, and聽LaBarge MA. NCI鈥檚 publication conundrum: Reframing聽innovation to incentivize an equitable path for advocate聽representation. Translational Oncology 2022 Feb;16:101325.听doi: 10.1016/j.tranon.2021.101325. Epub 2021 Dec 30. PMID:聽34974281.
• Gaafar NM, Osman TA, Ahmed IA, Elsheikh M, Dongre H,聽Jacobsen MR, Mohamed NG, Fromreide S, Suleiman AM,聽Johannessen AC, Nginamau ES, Costea DE. Characterization聽of immune cell infiltrate in tumor stroma and epithelial聽compartments in oral squamous cell carcinomas of Sudanese聽patients. Clin Exp Dent Res. 2022 Feb;8(1):130-140. doi:10.1002/cre2.501. Epub 2021 Oct 9. PMID: 34626165; PMCID:聽PMC8874073.
• Gundersen ET, F酶rde JL, Tislevoll BS, Leitch C, Barratt聽G, Gjertsen BT, Herfindal L. Repurposing chlorpromazine聽for anti-leukaemic therapy by nanoparticle encapsulation.听Int J Pharm. 2022 Jan 25;612:121296. doi: 10.1016/j.ijpharm.2021.121296. Epub 2021 Nov 15. PMID: 34793932.
• Liu XZ, Rulina A, Choi MH, Pedersen L, Lepland J, Takle聽ST, Madeleine N, Peters SD, Wogsland CE, Gr酶ndal SM,聽Lorens JB, Goodarzi H, L酶nning PE, Knappskog S, Molven聽A, Halberg N. C/EBPB-dependent adaptation to palmitic聽acid promotes tumor formation in hormone receptor negative聽breast cancer. Nat Commun. 2022 Jan 10;13(1):69. doi: 10.1038/s41467-021-27734-2. PMID: 35013251; PMCID: PMC8748947.听
• Dybvik JA, Fasmer KE, Ytre-Hauge S, Husby JHA, Salvesen聽脴O, Stefansson IM, Krakstad C, Trovik J, Haldorsen IS.听MRI-assessed tumor-free distance to serosa predicts deep聽myometrial invasion and poor outcome in endometrial cancer.听Insights Imaging. 2022 Jan 8;13(1):1. doi: 10.1186/s13244-021-01133-z. PMID: 35000020; PMCID: PMC8742796.
• Kang J, Cairns J. Protocol for data extraction: how real-world聽data have been used in the National Institute for Health and聽Care Excellence appraisals of cancer therapy. BMJ Open. 2022聽Jan 6;12(1):e055985. doi: 10.1136/bmjopen-2021-055985. PMID:
  34992121; PMCID: PMC8739419.
• Shanbhag S, Kampleitner C, Mohamed-Ahmed S,聽Yassin MA, Dongre H, Costea DE, Tangl S, Hassan MN,聽Stavropoulos A, Bolstad AI, Suliman S, Mustafa K.听Corrigendum: Ectopic Bone Tissue Engineering in Mice Using聽Human Gingiva or Bone Marrow-Derived Stromal/Progenitor聽Cells in Scaffold-Hydrogel Constructs. Front Bioeng Biotechnol.听2022 Jan 4;9:831669. doi: 10.3389/fbioe.2021.831669. Erratum聽for: Front Bioeng Biotechnol. 2021 Nov 30;9:783468. PMID:聽35059391; PMCID: PMC8764244.
• Harryvan TJ, Hawinkels LJAC; mini-tumor workgroup;聽脰stman A, Ten Dijke P, Strell C, Hornsveld M. A Novel聽Pancreatic Cancer Mini-tumor Model to Study Desmoplasia听补苍诲 Myofibroblastic Cancer-Associated Fibroblast聽Differentiation. Gastro Hep Adv.听2022;1(4):678-681. doi:10.1016/j.gastha.2022.04.019. PMID: 35937541; PMCID:聽PMC9340885.
• Popa M, Fosse V, Kleinmanns K, Bj酶rge L, McCormack E.听Xenograft Models of Ovarian Cancer for Therapy Evaluation.听Methods Mol Biol. 2022;2424:275-293. doi: 10.1007/978-1-0716-1956-8_18. PMID: 34918301.听
• Aamdal E, Jacobsen KD, Straume O, Kersten C, Herlofsen O,聽Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M,聽Schuster C, Hagene KT, Holmsen K, Russnes HG, Skovlund聽E, Kaasa S, Aamdal S, Kyte JA, Guren TK. Ipilimumab in聽a real-world population: A prospective Phase IV trial with聽long-term follow-up. Int J Cancer. 2022 Jan 1;150(1):100-111.听doi: 10.1002/ijc.33768. Epub 2021 Sep 9. PMID: 34449877.听
• Forsse D, Barbero ML, Werner HMJ, Woie K, Nordskar聽N, Berge Nilsen E, Ellstr酶m Engh M, Vistad I, Rege A,聽S忙vik-Lode M, Andreasen S, Haldorsen IS, Trovik J,聽Krakstad C. Longitudinal effects of adjuvant chemotherapy听补苍诲 lymph node staging on patient-reported outcomes in聽endometrial cancer survivors: a prospective cohort study. Am聽J Obstet Gynecol. 2022 Jan;226(1):90.e1-90.e20. doi: 10.1016/j.ajog.2021.08.011. Epub 2021 Aug 13. PMID: 34400137.听
• Zhang X, Groen K, Morten BC, Steffens Reinhardt L,聽Campbell HG, Braithwaite AW, Bourdon JC, Avery-Kiejda聽KA. Effect of p53 and its N-terminally truncated isoform,聽螖40p53, on breast cancer migration and invasion. Mol Oncol.听2022 Jan;16(2):447-465. doi: 10.1002/1878-0261.13118. Epub聽2021 Nov 23. PMID: 34657382; PMCID: PMC8763661.
• Watnick, RS. The Role of the Tumor Microenvironment in聽Regulating Angiogenesis. In: Akslen LA, Watnick RS (eds),聽Biomarkers of the Tumor Microenvironment, 2022, Springer, p.听3-15.听
• Akslen, LA. Tissue-Based Biomarkers of Tumor-Vascular聽Interactions. In: Akslen LA, Watnick RS (eds), Biomarkers of聽the Tumor Microenvironment, 2022, Springer, p. 17-30.听
• Milosevic M, Edelmann RJ, Fosse JH, 脰stman A, Akslen聽LA. Molecular Phenotypes of Endothelial Cells in Malignant聽Tumors. In: Akslen LA, Watnick RS (eds), Biomarkers of the聽Tumor Microenvironment, 2022, Springer, p. 31-52.
• Zeltz C, Navab R, Lu N, Kusche-Gullberg M, Tsao MS,聽Gullberg D. Role of the Extracellular Matrix in Tumor Stroma:聽Barrier or Support? In: Akslen LA, Watnick RS (eds), Biomarkers聽of the Tumor Microenvironment, 2022, Springer, p. 63-89.
• Dongre H, Costea DE. Tumor-Fibroblast Interactions in聽Carcinomas. In: Akslen LA, Watnick RS (eds), Biomarkers of聽the Tumor Microenvironment, 2022, Springer, p. 109-124.
• Strell C, 脰stman A. Stromal PDGF Receptors; Impact on聽Prognosis and Response to Treatment. In: Akslen LA, Watnick聽RS (eds), Biomarkers of the Tumor Microenvironment, 2022,聽Springer, p. 125-138.
• Brekken RA, Wnuk-Lipinska K. Drivers of EMT and Immune聽Evasion. In: Akslen LA, Watnick RS (eds), Biomarkers of the聽Tumor Microenvironment, 2022, Springer, p. 183-194.
• Vethe H, Bj酶rnstad OV, Carrasco M, Akslen LA.听Neurogenesis in the Tumor Microenvironment. In: Akslen LA,聽Watnick RS (eds), Biomarkers of the Tumor Microenvironment,聽2022, Springer, p. 283-293.
• Lotsberg ML, Davidsen KT, Peters S, Haaland GS, Rayford聽A, Lorens JB, Engelsen AST. The Role of AXL Receptor聽Tyrosine Kinase in Cancer Cell Plasticity and Therapy聽Resistance. In: Akslen LA, Watnick RS (eds), Biomarkers of the聽Tumor Microenvironment, 2022, Springer, p. 307-327.
• Kleinmanns K, Gjerde CH, Langer A, Fosse V, de Jal贸n EG,聽Leitch C, Popa M, Gelebart P, McCormack E. Modeling the聽Tumor Microenvironment in Patient-Derived Xenografts:聽Challenges and Opportunities. In: Akslen LA, Watnick RS聽(eds), Biomarkers of the Tumor Microenvironment, 2022, Springer,聽p. 329-344.
• Wik E, Ingebriktsen LM, Akslen LA. Gene Expression聽Signatures of the Tumor Microenvironment: Relation to Tumor聽Phenotypes and Progress in Breast Cancer. In: Akslen LA,聽Watnick RS (eds), Biomarkers of the Tumor Microenvironment,聽2022, Springer, p. 401-424.
• Jokela TA, Carlson EG, LaBarge MA. The Influence of Tissue聽Architecture on Drug Response: Anticancer Drug Development聽in High-Dimensional Combinatorial Microenvironment聽Platforms. In: Akslen LA, Watnick RS (eds), Biomarkers of the聽Tumor Microenvironment, 2022, Springer, p. 441-452.
• Azeem W, Hua Y, Kalland KH, Ke X, Olsen JR, 脴yan AM,聽Qu Y. Models of Tumor Progression in Prostate Cancer.听In: Akslen LA, Watnick RS (eds), Biomarkers of the Tumor聽Microenvironment, 2022, Springer, p. 453-465.
• Magnussen AL, Mills IG. Prostate Cancer Biomarkers: The聽Old and the New. In: Akslen LA, Watnick RS (eds), Biomarkers聽of the Tumor Microenvironment, 2022, Springer, p. 467-482.听
• Ramnefjell M, Akslen LA. Tumor-Vascular Interactions in聽Non-Small Cell Lung Cancer. In: Akslen LA, Watnick RS (eds),聽Biomarkers of the Tumor Microenvironment, 2022, Springer, p. 497-508.听
• Dillek氓s D, Schuster C, Davidsen KT, Straume O. The聽Role of the Microenvironment in Tumor Promoting Stress聽Responses. In: Akslen LA, Watnick RS (eds), Biomarkers of the聽Tumor Microenvironment, 2022, Springer, p. 519-536.听
• Jebsen NL, Ktoridou-Valen I, Gjertsen BT. Biomarker Panels听补苍诲 Contemporary Practice in Clinical Trials of Personalized聽Medicine. In: Akslen LA, Watnick RS (eds), Biomarkers of the聽Tumor Microenvironment, 2022, Springer, p. 549-562.听
• Sim WJ, Lee KC, Thiery JP. Cancer Biomarkers: A Long and聽Tortuous Journey. In: Akslen LA, Watnick RS (eds), Biomarkers聽of the Tumor Microenvironment, 2022, Springer, p. 563-580.听
• Dillek氓s HE. 鈥淩econstruction of Trouble鈥�. In: Bremer A,聽Strand R (eds), Precision Oncology and Cancer Biomarkers. Human聽Perspectives in Health Sciences and Technology, 2022, Springer,聽p. 61-68.
• Gissum KR. Lost in Translation. In: Bremer A, Strand R (eds),聽Precision Oncology and Cancer Biomarkers. Human Perspectives in聽Health Sciences and Technology, 2022, Springer, p. 69-95.
• Bremer A, Wik E, Akslen LA. HER2 Revisited: Reflections聽on the Future of Cancer Biomarker Research. In: Bremer A,聽Strand R (eds), Precision Oncology and Cancer Biomarkers. Human聽Perspectives in Health Sciences and Technology, 2022, Springer,
  p. 97-119.
• Strand R, Chu D. Crossing the Styx: If Precision Medicine聽Were to Become Exact Science. In: Bremer A, Strand R (eds),聽Precision Oncology and Cancer Biomarkers. Human Perspectives聽in Health Sciences and Technology, 2022, Springer, p. 133-154.
• Lotsberg ML, Peters SA. Publication Bias in Precision聽Oncology and Cancer Biomarker Research; Challenges and聽Possible Implications. In: Bremer A, Strand R (eds), Precision聽Oncology and Cancer Biomarkers. Human Perspectives in Health聽Sciences and Technology, 2022, Springer, p. 155-174.
• Cairns, JA. Assessing the Cost-Effectiveness of Molecular聽Targeted Therapies and Immune Checkpoint Inhibitors.听In: Bremer A, Strand R (eds), Precision Oncology and Cancer聽Biomarkers. Human Perspectives in Health Sciences and Technology,
  2022, Springer, p. 175-185.
• Kang J. Real-World Data in Health Technology Assessment:聽Do We Know It Well Enough? In: Bremer A, Strand R (eds),聽Precision Oncology and Cancer Biomarkers. Human Perspectives聽in Health Sciences and Technology, 2022, Springer, p. 187-203
• Tranv氓g EJ, Strand R. Rationing of Personalised Cancer Drugs:聽Rethinking the Co-production of Evidence and Priority Setting聽Practices. In: Bremer A., Strand R. (eds) Precision Oncology and聽Cancer Biomarkers. Human Perspectives in Health Sciences and
  Technology, 2022, Springer, p. 235-250.
• Strand R, Engen C. Filled with Desire, Perceive Molecules.听In: Bremer A, Strand R (eds), Precision Oncology and Cancer聽Biomarkers. Human Perspectives in Health Sciences and Technology,聽2022, Springer, p. 251-267.
• Bertolaso M, Vela虂zquez H. The Epistemology of Life聽- Understanding living beings according to a relational聽ontology. In: Wuppuluri S, Stewart I (eds) From Electrons to聽Elephants and Elections: Exploring the Role of Content and Context,聽2022, Springer, p. 719-741.
• Bertolaso M. Complexity and Management: Epistemic Insights聽from Life Science. In: Neesham C, Reihlen M, Schoeneborn聽D (eds) Handbook of Philosophy of Management, 2022, Springer,聽p. 333-355.
• Bertolaso M, Capone L, Rodr矛guez-Llesma C (eds). Digital聽Humanism - A Human-Centric Approach to Digital聽Technologies, Palgrave 鈥� Springer, 2022.

2020

2019

2018

2017

2016

2015

2014

2013